Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acosta PB. Nutrition management of patients with inherited metabolic disorders. 1st ed. Sudbury: Jones & Bartlett Learning; 2009.
Pusti S, Das N, Nayek K, Biswas S. A treatable neurometabolic disorder: glutaric aciduria type 1. Case Rep Pediatr. 2014;2014:256356.
Hedlund GL, Longo N, Pasquali M. Glutaric acidemia type 1. Am J Med Genet C Semin Med Genet. 2006;142C(2):86–94.
Kolker S, Christensen E, Leonard JV, Greenberg CR, Boneh A, Burlina AB, et al. Diagnosis and management of glutaric aciduria type I—revised recommendations. J Inherit Metab Dis. 2011;34(3):677–94.
Harting I, Neumaier-Probst E, Seitz A, Maier EM, Assmann B, Baric I, et al. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain. 2009;132(Pt 7):1764–82.
Bahr O, Mader I, Zschocke J, Dichgans J, Schulz JB. Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology. 2002;59(11):1802–4.
Busquets C, Coll MJ, Merinero B, Ugarte M, Ruiz MA, Martinez Bermejo A, et al. Prenatal molecular diagnosis of glutaric aciduria type I by direct mutation analysis. Prenat Diagn. 2000;20(9):761–4.
Fernandez-Alvarez E, Garcia-Cazorla A, Sans A, Boix C, Vilaseca MA, Busquets C, et al. Hand tremor and orofacial dyskinesia: clinical manifestations of glutaric aciduria type I in a young girl. Mov Disord. 2003;18:1076–9.
Hoffmann GF, Athanassopoulos S, Burlina AB, Duran M, de Klerk JB, Lehnert W, et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 1996;27(3):115–23.
Kulkens S, Harting I, Sauer S, Zschocke J, Hoffmann GF, Gruber S, et al. Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology. 2005;64(12):2142–4.
Pierson TM, Nezhad M, Tremblay MA, Lewis R, Wong D, Salamon N, et al. Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules. Neurogenetics. 2015;16(4):325–8.
Strauss KA, Lazovic J, Wintermark M, Morton DH. Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain. 2007;130(Pt 7):1905–20.
Bernstein L, Coughlin CR, Drumm M, Yannicelli S, Rohr F. Inconsistencies in the nutrition management of glutaric aciduria type 1: an international survey. Nutrients. 2020;12(10):3162.
Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet. 2003;121C(1):38–52.
Thomas JA, Bernstein LE, Greene CL, Koeller DM. Apparent decreased energy requirements in children with organic acidemias: preliminary observations. J Am Diet Assoc. 2000;100(9):1074–6.
Strauss KA, Brumbaugh J, Duffy A, Wardley B, Robinson D, Hendrickson C, et al. Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab. 2011;104(1–2):93–106.
Zempleni J, Galloway JR, McCormick DB. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr. 1996;63(1):54–66.
Boy N, Muhlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40(1):75–101.
Boy N, Haege G, Heringer J, Assmann B, Muhlhausen C, Ensenauer R, et al. Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters. J Inherit Metab Dis. 2013;36(3):525–33.
Winter SC, Szabo-Aczel S, Curry CJ, Hutchinson HT, Hogue R, Shug A. Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child. 1987;141(6):660–5.
Brandt NJ, Gregersen N, Christensen E, Gron IH, Rasmussen K. Treatment of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria). Experience with diet, riboflavin, and GABA analogue. J Pediatr. 1979;94(4):669–73.
Chalmers RA, Bain MD, Zschocke J. Riboflavin-responsive glutaryl CoA dehydrogenase deficiency. Mol Genet Metab. 2006;88(1):29–37.
Kolker S, Sauer SW, Okun JG, Hoffmann GF, Koeller DM. Lysine intake and neurotoxicity in glutaric aciduria type I: towards a rationale for therapy? Brain. 2006;129(Pt 8):e54.
Mc MR, Oncley JL. The specific binding of L-tryptophan to serum albumin. J Biol Chem. 1958;233(6):1436–47.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bernstein, L.E. (2022). Nutrition Management of Glutaric Acidemia Type 1. In: Bernstein, L.E., Rohr, F., van Calcar, S. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-94510-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-94510-7_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94509-1
Online ISBN: 978-3-030-94510-7
eBook Packages: MedicineMedicine (R0)